![](/images/graphics-bg.png)
A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death
المؤلفون المشاركون
Debois, Patrick
Claerhout, Filip
Keirse, Marc J. N. C.
Van Mensel, Kristin
Hanssens, Myriam
المصدر
Obstetrics and Gynecology International
العدد
المجلد 2009، العدد 2009 (31 ديسمبر/كانون الأول 2009)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2009-09-06
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Objective.
To compare effectiveness, side effects, and patients' perception of vaginal misoprostol versus intravenous sulprostone for ending pregnancy after fetal death between 14 and 42 weeks gestation.
Method.
Multicenter randomized controlled trial, using block randomization, central allocation, and prior power analysis.
Outcome measures.
Induction-delivery interval, gastrointestinal side effects, use of analgesia, pain perception, pyrexia, placental retention, hemorrhage, and women's opinions.
Results.
Of 176 women aimed for, 143 were randomized over 7 years, of whom 4 were excluded.
There was no difference in delivery within 24 and 36 hours: 91.4% and 97.1% with misoprostol (n=70) versus 85.5% and 92.8% with sulprostone (n=69).
There was no difference in either gastrointestinal side effects, as reported by the women and their caregivers, use of analgesia, women's pain perception, blood loss or placental retention.
Hyperthermia ≥38°C was more common with misoprostol (24.3%) than with sulprostone (11.6%; difference: +12.7%; 95% CI: +1.2% to +25.3%) and related to the total dose used.
Acceptability of both induction methods was similar except for freedom of movement, which was substantially in favor of misoprostol (lack of freedom reported with misoprostol in 34.3% versus 63.8% with sulprostone; difference: −29.5%; 95% CI: −13.6% to −45.4%).
Conclusions.
Misoprostol and sulprostone are similarly effective with little difference in side effects except for hyperthermia, related to the dose of misoprostol used, and women's reported lack of mobility with intravenous sulprostone.
Effectiveness of both methods increased with gestational age.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Van Mensel, Kristin& Claerhout, Filip& Debois, Patrick& Keirse, Marc J. N. C.& Hanssens, Myriam. 2009. A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death. Obstetrics and Gynecology International،Vol. 2009, no. 2009, pp.1-8.
https://search.emarefa.net/detail/BIM-476302
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Van Mensel, Kristin…[et al.]. A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death. Obstetrics and Gynecology International No. 2009 (2009), pp.1-8.
https://search.emarefa.net/detail/BIM-476302
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Van Mensel, Kristin& Claerhout, Filip& Debois, Patrick& Keirse, Marc J. N. C.& Hanssens, Myriam. A Randomized Controlled Trial of Misoprostol and Sulprostone to End Pregnancy after Fetal Death. Obstetrics and Gynecology International. 2009. Vol. 2009, no. 2009, pp.1-8.
https://search.emarefa.net/detail/BIM-476302
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-476302
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)